AplusA 30+ years Anniversary - Interview #1
In ‘21, we are celebrating our 30+.
AplusA is actually 30+ years old this year... But what does it...
AplusA Anniversaire 30+ ans - Interview #1
C’est l’année 21, mais nous en célébrons plus de 30.
En 2021, AplusA fête - non pas ses 30 - mais...
Our brand new 2020 Syndicated Surveys
Our range of syndicated studies now covers over 30 indications, many of them with results already...
COVID-19 2nd Phase - Impact on Physicians’ Practice - Syndicated Study
How does COVID-19 affectthe HCPS relationships with patients and with the pharmaceutical industry?...
mRCC: promising new combinations lead to disruption in L1 and L2
Targeted therapies, particularly tyrosine kinase inhibitors (TKI) dominate the treatment of...
COVID-19 road to recovery: 5 key insights from our syndicated study
As the global number of infected cases surpasses 46 million (Nov 2, 2020), there is a non-stop...
Social Media Insights: ASCO 2020 Part 2
hemato-oncology, Social Media Listening, Oncology
TheAmerican Society of Oncologists (ASCO) annual meetingisa majorfixture in theglobal oncology
Welcoming the new-look AplusA website!
You might have noticed that our site looks a little different. We wanted to share the story behind...
DLBCL Patient Insights in the US and EU5
hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies
When working on a new or existing brand within the DLBCL market it's important to have up to date...
Social Media Insights: ASCO 2020 Part 1
hemato-oncology, Social Media Listening, Oncology
TheAmerican Society of Oncologists (ASCO) annual meetingisa majorfixture in theglobal oncology